Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany's Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis

Attachment	Size
2022-08-09-Curaleaf-Announces-Majority-Stake-and-Forms-Strategic-Partnership-with-Germanys-Four-20-Pharma-a-Fully-EU-GMP-GDP-Licensed-Producer-and-Distributor-of-Medical-Cannabis.pdf	34.77 KB